AU
UK
CA
NZ
IND
US
Exagen Inc. (NASDAQ: XGN) surged 25.42 per cent to $3.70 on Tuesday after the medical diagnostics company reported a first quarter that exceeded expectations on the metrics that matter most for a diagnosticsBusinessat this stage of its commercial development: volume, pricing, and the trajectory …
Actuate Therapeutics (NASDAQ: ACTU) suffered a sharpReversalon Tuesday, declining 11.82 per cent to $2.91, in what may rank as one of the more counterintuitive market reactions of the day. The company had just announced that the US Food and Drug Administration had cleared its …
Longeveron Inc. (NASDAQ: LGVN) barely moved on Tuesday, edging up just 0.59 per cent to $0.8502, in a muted market response to a regulatory development that, in a different sentiment environment, might have been expected to hit the stock considerably harder. The company disclosed …
Key Highlights
Key Highlights
USEquitymarkets ended Friday on a positive note, with the S&P 500 advancing 0.8% to close at 7,399 and theNasdaqComposite climbing 1.7% to 26,247, both reaching new record highs. TheDow Jones Industrial Averagealso posted modest gains, rising 12 points to 49,609. Investor confidence was supported …
Please wait processing your request...